This grant aims to identify drug and formulation factors causing alcohol-induced rapid release from modified-release drugs, improving testing and development for safer generics.
This grant aims to improve prediction of food/drug interactions for high-risk oral drugs by using a lab model that mimics the gut to assess drug performance.
Supports preclinical and clinical research to develop interventions to prevent or treat substance use disorders and overdose, advancing candidates toward regulatory approval or clinical adoption.
NIDA seeks to support shared drug-development infrastructure to help academic and biotech researchers repurpose medications for substance use disorders and advance them toward clinical development.
Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.
Funding for collaborative research on new treatments for mental disorders, substance use disorders, and alcohol use disorder, emphasizing novel drugs/devices and industry-academic partnerships.